Upgrade to SI Premium - Free Trial

Deutsche Bank Says Pfizer (PFE) and Allergan (AGN) Deal Would Enhance Cash Access

October 29, 2015 2:28 PM
Deutsche Bank maintained a Buy rating on Pfizer (NYSE: PFE) with a price target of $43. Comments follow rumors related ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments

Next Articles